editorial immune responses to rna virusesdownloads.hindawi.com/journals/jir/2018/5473678.pdf ·...

3
Editorial Immune Responses to RNA Viruses Elias A. Said , 1 Felipe Diaz-Griffero, 2 Dorine Bonte, 3,4 Daniel Lamarre , 5 and Ali A. Al-Jabri 1 1 Department of Microbiology and Immunology, College of Medicine and Health Sciences, Sultan Qaboos University, P.O. Box: 35, 123 Muscat, Oman 2 Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York City, NY, USA 3 CNRS UMR8200, Gustave Roussy Cancer Institute, Paris, France 4 College of Pharmacy, Paris-Sud University, Paris, France 5 Centre de Recherche du CHUM (CRCHUM) et Faculté de Médecine, Université de Montréal, Montréal, QC, Canada Correspondence should be addressed to Elias A. Said; [email protected], Daniel Lamarre; [email protected], and Ali A. Al-Jabri; [email protected] Received 9 May 2018; Accepted 9 May 2018; Published 12 June 2018 Copyright © 2018 Elias A. Said et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. RNA viruses constitute an important threat to human health around the globe. Several RNA viruses are pan- demic and infect hundreds of millions around the world leading to the death of millions of people every year. These viruses include the human immunodeciency virus (HIV), hepatitis C virus (HCV), Ebola virus, Zika virus, respiratory syncytial virus (RSV), inuenza viruses, yellow fever virus, dengue virus, rhinoviruses (common cold), human T-lymphotropic virus type 1 (HTLV-I), poliovirus, and measles virus. Currently, no vaccine or specic treatment is available for many of these viruses and some of the available vaccines and treatments are not highly eective. Because infection with RNA viruses is a global issue, the Journal of Immunology Research arranged for the publica- tion of a special issue dedicated to the topic of immune responses to RNA viruses. The special issue contains 3 reviews and 2 research articles submitted by researchers from 6 countries in Europe, Asia, America, and Africa. These articles emphasized on the importance of the relationship between the components of the immune system and the treatments and vaccines directed against RNA viruses. They also highlighted the role of the immune system in the pathogenesis of the infections with these viruses. HIV infection is a good example of the interactions between an RNA virus and the immune system and how these interactions modulate the pathophysiology of the disease caused by the virus. In this special issue, 3 articles focused on HIV infection. I. E. Akase et al. showed in Immune Dysfunction in HIV: A Possible Role for Pro- and Anti-Inammatory Cytokines in HIV Stagingthat the levels of proinammatory cytokines IL-6 and IL-10 are elevated in the absence of anti-HIV treatment. These cytokines, particularly IL-6, were associated with the WHO clinical staging of the disease. A trend of association was also found between these cytokines and the CD4 T cell count in HIV-infected patients. Moreover, L. Herráiz-Nicuesa et al. reported in their article entitled Impact of the Polymor- phism rs9264942 near the HLA-C Gene on HIV-1 DNA Reservoirs in Asymptomatic Chronically Infected Patients Initiating Antiviral Therapythat the -35 C allele is associated with low viremia and low levels of HIV reservoir. However, these associations did not reach statistical signi- cance after thirty-six months of therapy. In addition, G. V. Gonzalez-Enriquez et al. reviewed in SERINC as a Restric- tion Factor to Inhibit Viral Infectivity and the Interaction with HIVthe capacity of some HIV proteins, that is, Nef, Env, and glycosylated Gag (glycoGag), to interfere with the activity of serine incorporator 5 (SERINC5) restriction fac- tor that prevents fusion and hence inhibits viral infectivity. The authors proposed that SERINC5 can be considered as an element in promising scenariosaiming to develop anti-HIV treatments and to predict the prognosis of the Hindawi Journal of Immunology Research Volume 2018, Article ID 5473678, 2 pages https://doi.org/10.1155/2018/5473678

Upload: others

Post on 23-Oct-2020

7 views

Category:

Documents


0 download

TRANSCRIPT

  • EditorialImmune Responses to RNA Viruses

    Elias A. Said ,1 Felipe Diaz-Griffero,2 Dorine Bonte,3,4 Daniel Lamarre ,5

    and Ali A. Al-Jabri 1

    1Department of Microbiology and Immunology, College of Medicine and Health Sciences, Sultan Qaboos University, P.O. Box: 35,123 Muscat, Oman2Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York City, NY, USA3CNRS UMR8200, Gustave Roussy Cancer Institute, Paris, France4College of Pharmacy, Paris-Sud University, Paris, France5Centre de Recherche du CHUM (CRCHUM) et Faculté de Médecine, Université de Montréal, Montréal, QC, Canada

    Correspondence should be addressed to Elias A. Said; [email protected], Daniel Lamarre; [email protected],and Ali A. Al-Jabri; [email protected]

    Received 9 May 2018; Accepted 9 May 2018; Published 12 June 2018

    Copyright © 2018 Elias A. Said et al. This is an open access article distributed under the Creative Commons Attribution License,which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

    RNA viruses constitute an important threat to humanhealth around the globe. Several RNA viruses are pan-demic and infect hundreds of millions around the worldleading to the death of millions of people every year.These viruses include the human immunodeficiency virus(HIV), hepatitis C virus (HCV), Ebola virus, Zika virus,respiratory syncytial virus (RSV), influenza viruses, yellowfever virus, dengue virus, rhinoviruses (common cold),human T-lymphotropic virus type 1 (HTLV-I), poliovirus,and measles virus. Currently, no vaccine or specific treatmentis available for many of these viruses and some of theavailable vaccines and treatments are not highly effective.Because infection with RNA viruses is a global issue, theJournal of Immunology Research arranged for the publica-tion of a special issue dedicated to the topic of immuneresponses to RNA viruses. The special issue contains3 reviews and 2 research articles submitted by researchersfrom 6 countries in Europe, Asia, America, and Africa. Thesearticles emphasized on the importance of the relationshipbetween the components of the immune system and thetreatments and vaccines directed against RNA viruses. Theyalso highlighted the role of the immune system in thepathogenesis of the infections with these viruses.

    HIV infection is a good example of the interactionsbetween an RNA virus and the immune system and howthese interactions modulate the pathophysiology of the

    disease caused by the virus. In this special issue, 3 articlesfocused on HIV infection. I. E. Akase et al. showed in“Immune Dysfunction in HIV: A Possible Role for Pro-and Anti-Inflammatory Cytokines in HIV Staging” that thelevels of proinflammatory cytokines IL-6 and IL-10 areelevated in the absence of anti-HIV treatment. Thesecytokines, particularly IL-6, were associated with the WHOclinical staging of the disease. A trend of association was alsofound between these cytokines and the CD4 T cell count inHIV-infected patients. Moreover, L. Herráiz-Nicuesa et al.reported in their article entitled “Impact of the Polymor-phism rs9264942 near the HLA-C Gene on HIV-1 DNAReservoirs in Asymptomatic Chronically Infected PatientsInitiating Antiviral Therapy” that the −35 C allele isassociated with low viremia and low levels of HIV reservoir.However, these associations did not reach statistical signifi-cance after thirty-six months of therapy. In addition, G. V.Gonzalez-Enriquez et al. reviewed in “SERINC as a Restric-tion Factor to Inhibit Viral Infectivity and the Interactionwith HIV” the capacity of some HIV proteins, that is, Nef,Env, and glycosylated Gag (glycoGag), to interfere with theactivity of serine incorporator 5 (SERINC5) restriction fac-tor that prevents fusion and hence inhibits viral infectivity.The authors proposed that SERINC5 can be considered asan element in “promising scenarios” aiming to developanti-HIV treatments and to predict the prognosis of the

    HindawiJournal of Immunology ResearchVolume 2018, Article ID 5473678, 2 pageshttps://doi.org/10.1155/2018/5473678

    http://orcid.org/0000-0003-4224-6351http://orcid.org/0000-0002-7325-2810http://orcid.org/0000-0003-2870-6067https://doi.org/10.1155/2018/5473678

  • disease. Additionally, in their review “Viruses Seen by OurCells: The Role of Viral RNA Sensors,” E. A. Said et al.discussed the implication of Toll-like receptors 3, 7, and 8(TLRs 3, 7, and 8) in mounting proper anti-HIV responsesand they reviewed the possibilities of targeting these mole-cules in future anti-HIV therapies and vaccine preparations.

    The innate immune system plays a key role in sensingRNA viruses. This has a major influence on the antiviralresponses and the pathogenesis of diseases caused by theseRNA viruses. In their article, E. A. Said et al. also reviewedthe role of pathogen recognition receptors (PRRs) in detect-ing nucleic acids as pathogen-associated molecular patterns(PAMPs) present in RNA viruses and how they balance theneed for innate defenses against pathogens and activelyrestrict involuntary pathway activation. Moreover, theydescribed the nature of the ligands and the pathways relatedto classic RNA helicases of antiviral innate immunity (RIG-I,MDA5) and of sentinel sensors (LGP2, SNRNP200, andDDX60) as well as of TLRs 3, 7, and 8 upon infection. Theyalso reported on the implication of these molecules in thepathogenesis of the diseases caused by RNA viruses and thepotential therapies and vaccines that involve these PRRs. Inaddition, in the review “Pulmonary Susceptibility of Neo-nates to Respiratory Syncytial Virus Infection: A Problemof Innate Immunity?,” C. Drajac et al. questioned the roleof the innate immune system in the susceptibility of neonatesto the infection with RSV. They discussed the knowledgeabout the immune environment in the lung during theearly-life periods at steady state and following RSV infection.They also reviewed the different experimental strategies thataimed to modulate the neonatal susceptibility to RSV.

    Altogether, the authors of these articles highlighted thedanger that infections with RNA viruses represent to globalhealth. They provided clues about how understanding andinterfering with the immune responses during these infec-tions can be a major asset in the attempt to eradicate theseviral infections. In summary, this special issue is providinginformation about different aspects of the immune responsesduring infections with RNA viruses. It is reporting on thecurrent challenges in the field and providing new perspec-tives for the development of efficient treatments and vaccinesdirected against RNA viruses.

    Elias A. SaidFelipe Diaz-Griffero

    Dorine BonteDaniel LamarreAli A. Al-Jabri

    2 Journal of Immunology Research

  • Stem Cells International

    Hindawiwww.hindawi.com Volume 2018

    Hindawiwww.hindawi.com Volume 2018

    MEDIATORSINFLAMMATION

    of

    EndocrinologyInternational Journal of

    Hindawiwww.hindawi.com Volume 2018

    Hindawiwww.hindawi.com Volume 2018

    Disease Markers

    Hindawiwww.hindawi.com Volume 2018

    BioMed Research International

    OncologyJournal of

    Hindawiwww.hindawi.com Volume 2013

    Hindawiwww.hindawi.com Volume 2018

    Oxidative Medicine and Cellular Longevity

    Hindawiwww.hindawi.com Volume 2018

    PPAR Research

    Hindawi Publishing Corporation http://www.hindawi.com Volume 2013Hindawiwww.hindawi.com

    The Scientific World Journal

    Volume 2018

    Immunology ResearchHindawiwww.hindawi.com Volume 2018

    Journal of

    ObesityJournal of

    Hindawiwww.hindawi.com Volume 2018

    Hindawiwww.hindawi.com Volume 2018

    Computational and Mathematical Methods in Medicine

    Hindawiwww.hindawi.com Volume 2018

    Behavioural Neurology

    OphthalmologyJournal of

    Hindawiwww.hindawi.com Volume 2018

    Diabetes ResearchJournal of

    Hindawiwww.hindawi.com Volume 2018

    Hindawiwww.hindawi.com Volume 2018

    Research and TreatmentAIDS

    Hindawiwww.hindawi.com Volume 2018

    Gastroenterology Research and Practice

    Hindawiwww.hindawi.com Volume 2018

    Parkinson’s Disease

    Evidence-Based Complementary andAlternative Medicine

    Volume 2018Hindawiwww.hindawi.com

    Submit your manuscripts atwww.hindawi.com

    https://www.hindawi.com/journals/sci/https://www.hindawi.com/journals/mi/https://www.hindawi.com/journals/ije/https://www.hindawi.com/journals/dm/https://www.hindawi.com/journals/bmri/https://www.hindawi.com/journals/jo/https://www.hindawi.com/journals/omcl/https://www.hindawi.com/journals/ppar/https://www.hindawi.com/journals/tswj/https://www.hindawi.com/journals/jir/https://www.hindawi.com/journals/jobe/https://www.hindawi.com/journals/cmmm/https://www.hindawi.com/journals/bn/https://www.hindawi.com/journals/joph/https://www.hindawi.com/journals/jdr/https://www.hindawi.com/journals/art/https://www.hindawi.com/journals/grp/https://www.hindawi.com/journals/pd/https://www.hindawi.com/journals/ecam/https://www.hindawi.com/https://www.hindawi.com/